Consumer health brands targeting Australia and New Zealand are confronting a persistent awareness gap where eye health is viewed independently from brain and cognitive function, according to the product development team at Lifestream. Vision serves as a primary source of sensory input for the brain, while cognitive processes like attention, memory, and perception influence how … Read more
City of Hope investigators have formulated an innovative plug-and-play technique that incorporates engineered molecules into chimeric antigen receptor (CAR) T cells post-treatment, based on findings shared this month in Cancer Immunology Research, an American Association for Cancer Research journal. The preclinical study offers a flexible approach to help CAR T cells keep pace with mutating … Read more
Researchers at the Institute for Neurosciences, a joint centre of the Miguel Hernández University of Elche and the Spanish National Research Council, have identified elevated levels of the active form of the protein meprin-β in the brain and cerebrospinal fluid of Alzheimer’s disease patients, providing new insights into beta-amyloid processing. Meprin-β Elevation in Alzheimer’s Brain … Read more
Young people living with HIV achieve better viral suppression when receiving antiretroviral therapy via injections every eight weeks compared to daily tablets, according to clinical trial findings published in The Lancet and presented at the World AIDS Conference by UCL researchers. The LATA trial demonstrated that two-month long-acting cabotegravir and rilpivirine injections reduced viral rebound … Read more
Acute kidney injury affects up to 60 percent of intensive care patients worldwide, presenting a major challenge for critical care medicine that now has standardized clinical guidance. According to the Journal of Intensive Medicine, a multidisciplinary expert panel organized by the Chinese Society of Critical Care Medicine published comprehensive guidelines on August 18, 2026, establishing … Read more
Interferon-alpha treats myeloproliferative neoplasms such as essential thrombocythemia by forcing mutant blood stem cells to rapidly mature into short-lived neutrophils, according to a study published in Nature Genetics by Weill Cornell Medicine investigators. The biologic drug also balances myeloid and lymphoid cell production while depleting malignant cell pools in the bone marrow, though its broad … Read more
Patients with major depressive disorder and an inadequate response to standard antidepressants who receive add-on treatment with lumateperone experience significant improvements in sexual function, according to a study published in The Journal of Clinical Psychiatry and led by University of Virginia School of Medicine researcher Anita H. Clayton. In the 480-patient trial, a daily 42 … Read more
Patients with small-cell lung cancer (SCLC) undergoing regular brain MRI surveillance without prophylactic cranial irradiation (PCI) achieved significantly better cognitive failure–free survival, according to phase III randomized trial results presented at the Presidential Symposium of the IASLC 2026 World Conference on Lung Cancer in Seoul, Republic of Korea. Researchers reported that MRI surveillance alone improved … Read more
Adding local consolidative therapy after induction treatment with nivolumab plus ipilimumab does not improve overall survival or progression-free survival in patients with metastatic non-small cell lung cancer, including those with oligometastatic disease, according to phase III trial results presented at the International Association for the Study of Lung Cancer 2026 World Conference on Lung Cancer. … Read more
Food and Drug Administration this week to test genetically engineered CAR T-cell immune cells in adults with advanced colorectal cancer and pediatric patients with solid tumors, according to university announcements. The experimental therapy attacks two specific targets, B7-H3 and IL-8, aiming to overcome the defenses of solid tumors where standard treatments have failed. University of … Read more